Effect of type 1 diabetes on the production and vasoactivity of hydrogen sulfide in rat middle cerebral arteries

Physiological Reports

Volumn 1, Issue 5, 2013, Pages

  Streeter, Elosie Y ^a   Badoer, Emilio ^a   Woodman, Owen L ^a   Hart, Joanne L ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Cerebral artery; Diabetes; Hydrogen sulfide; Oxidative stress

Indexed keywords

BRADYKININ; CHLORIDE CHANNEL; CYSTATHIONINE GAMMA LYASE; CYSTEINE; EGTAZIC ACID; GLUCOSE; HYDROGEN SULFIDE; LUCIGENIN; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; BRAIN TISSUE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE CEREBRAL ARTERY; MRNA EXPRESSION ASSAY; NONHUMAN; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VASOACTIVITY; VASODILATATION;

EID: 85009067252     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.111     Document Type: Article

References (48)

1. Al-Magableh, M. R., and J. L. Hart. 2011. Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn Schmiedebergs Arch. Pharmacol. 383: 403–413.
2. Brancaleone, V., F. Roviezzo, V. Vellecco, L. de Gruttola, M. Bucci, and G. Cirino. 2008. Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br. J. Pharmacol. 155: 673–680.
3. Bultmann, R., and K. Starke. 1994. Blockade by 4, 4′-diisothiocyanatostilbene-2, 2′-disulphonate (DIDS) of P2X-purinoceptors in rat vas deferens. Br. J. Pharmacol. 112: 690–694.
4. Carballal, S., M. Trujillo, E. Cuevasanta, S. Bartesaghi, M. N. Moller, L. K. Folkes, et al. 2011. Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic. Biol. Med. 50: 196–205.
5. Deleon, E. R., G. F. Stoy, and K. R. Olson. 2012. Passive loss of hydrogen sulfide in biological experiments. Anal. Biochem. 421: 203–207.
6. Denizalti, M., T. E. Bozkurt, U. Akpulat, I. Sahin-Erdemli, and N. Abacioglu. 2011. The vasorelaxant effect of hydrogen sulfide is enhanced in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch. Pharmacol. 383: 509–517.
7. Favaloro, J., K. Andrews, and G. McPherson. 2003. Novel imidazoline compounds that inhibit kir-mediated vasorelaxation in rat middle cerebral artery. Naunyn-Schmeideberg’s Arch. Pharmacol. 367: 397–405.
8. Furne, J., A. Saeed, and M. D. Levitt. 2008. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295: R1479–R1485.
9. Gojkovic-Bukarica, L., A. Hambrock, C. Loffler-Walz, U. Quast, and U. Russ. 2002. Mg2+ sensitizes KATP channels to inhibition by DIDS: dependence on the sulphonylurea receptor subunit. Br. J. Pharmacol. 137: 429–440.
10. Gryglewski, R. J., R. M. Palmer, and S. Moncada. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454–456.
11. Gunarathne, A., J. V. Patel, S. Kausar, B. Gammon, E. A. Hughes, and G. Y. Lip. 2009. Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham stroke project. Stroke 40: 2298–2306.
12. Hassan, M. I., M. Boosen, L. Schaefer, J. Kozlowska, F. Eisel, A. von Knethen, et al. 2012. Platelet-derived growth factor-BB induces cystathionine gamma-lyase expression in rat mesangial cells via a redox-dependent mechanism. Br. J. Pharmacol. 166: 2231–2242.
13. Hill, A. P., and R. Sitsapesan. 2002. DIDS modifies the conductance, gating, and inactivation mechanisms of the cardiac ryanodine receptor. Biophys. J. 82: 3037–3047.
14. Kaneko, Y., T. Kimura, S. Taniguchi, M. Souma, Y. Kojima, Y. Kimura, et al. 2009. Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose. FEBS Lett. 583: 377–382.
15. Kitayama, J., F. M. Faraci, C. A. Gunnett, and D. D. Heistad. 2006. Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase. Stroke 37: 2129–2133.
16. Komatsu, S., Y. Okazaki, M. Tateno, J. Kawai, H. Konno, M. Kusakabe, et al. 2000. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem. Biophys. Res. Commun. 267: 109–117.
17. Leffler, C. W., H. Parfenova, S. Basuroy, J. H. Jaggar, E. S. Umstot, and A. L. Fedinec. 2011. Hydrogen sulfide and cerebral microvascular tone in newborn pigs. Am. J. Physiol. Heart Circ. Physiol. 300: H440–H447.
18. Leo, C. H., A. Joshi, and O. L. Woodman. 2010. Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery. Am. J. Physiol. Heart Circ. Physiol. 299: H502–H511.
19. Leo, C. H., J. L. Hart, and O. L. Woodman. 2011a. 3′, 4′-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PLoS ONE 6: e20813.
20. Leo, C. H., J. L. Hart, and O. L. Woodman. 2011b. 3′, 4′-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes. Eur. J. Pharmacol. 659: 193–198.
21. Leo, C. H., J. L. Hart, and O. L. Woodman. 2011c. Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. Br. J. Pharmacol. 162: 365–377.
22. Li, L., M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, et al. 2008. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117: 2351–2360.
23. Liang, G. H., A. Adebiyi, M. D. Leo, E. M. McNally, C. W. Leffler, and J. H. Jaggar. 2011. Hydrogen sulfide dilates cerebral arterioles by activating smooth muscle cell plasma membrane KATP channels. Am. J. Physiol. Heart Circ. Physiol. 300: H2088–H2095.
24. Liu, J., Z. F. Lai, X. D. Wang, N. Tokutomi, and K. Nishi. 1998. Inhibition of sodium current by chloride channel blocker 4, 4′-diisothiocyanatostilbene-2, 2′-disulfonic acid (DIDS) in guinea pig cardiac ventricular cells. J. Cardiovasc. Pharmacol. 31: 558–567.
25. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 25: 402–408.
26. Mackenzie, A., and W. Martin. 1998. Loss of endothelium-derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics. Br. J. Pharmacol. 124: 719–728.
27. Marcotte, P., and C. Walsh. 1976. Vinylglycine and proparglyglycine: complementary suicide substrates for L-amino acid oxidase and D-amino acid oxidase. Biochemistry 15: 3070–3076.
28. Miller, A. A., G. R. Drummond, H. H. Schmidt, and C. G. Sobey. 2005. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ. Res. 97: 1055–1062.
29. Muzaffar, S., J. Y. Jeremy, A. Sparatore, P. del Soldato, G. D. Angelini, and N. Shukla. 2008a. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br. J. Pharmacol. 155: 984–994.
30. Muzaffar, S., N. Shukla, M. Bond, A. C. Newby, G. D. Angelini, A. Sparatore, et al. 2008b. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J. Vasc. Res. 45: 521–528.
31. Nazir, F. S., M. Alem, M. Small, J. M. Connell, K. R. Lees, M. R. Walters, et al. 2006. Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabet. Med. 23: 398–402.
32. Quinn, T. J., J. Dawson, and M. R. Walters. 2011. Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovasc. Ther. 29: e31–e42.
33. Rask-Madsen, C., and G. L. King. 2007. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 3: 46–56.
34. Selemidis, S., C. G. Sobey, K. Wingler, H. H. Schmidt, and G. R. Drummond. 2008. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 120: 254–291.
35. Shen, G. X. 2010. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. Can. J. Physiol. Pharmacol. 88: 241–248.
36. Shibuya, N., Y. Mikami, Y. Kimura, N. Nagahara, and H. Kimura. 2009. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 146: 623–626.
37. Stasko, A., V. Brezova, M. Zalibera, S. Biskupic, and K. Ondrias. 2009. Electron transfer: a primary step in the reactions of sodium hydrosulphide, an H2S/HS (-) donor. Free Radic Res. 43: 581–593.
38. Streeter, E., J. Hart, and E. Badoer. 2012. An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries. Naunyn Schmiedebergs Arch. Pharmacol. 385: 991–1002.
39. Streeter, E., H. H. Ng, and J. L. Hart. 2013. Hydrogen sulfide as a vasculoprotective factor. Med. Gas Res. 3: 9.
40. Thompson, G. A., A. H. Datko, and S. H. Mudd. 1982. Methionine synthesis in lemna: inhibition of cystathionine gamma-synthase by propargylglycine. Plant Physiol. 70: 1347–1352.
41. Tian, X. Y., W. T. Wong, N. Sayed, J. Luo, S. Y. Tsang, Z. X. Bian, et al. 2012. NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+ channel. Pharmacol. Res. 65: 239–246.
42. de Vriese, A. S., T. J. Verbeuren, J. van de Voorde, N. H. Lameire, and P. M. Vanhoutte. 2000. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130: 963–974.
43. Whiteman, M., J. Armstong, S. Chu, S. Jia-Ling, B. Wong, N. Cheung, et al. 2004. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? J. Neurochem. 90: 765–768.
44. Whiteman, M., N. Cheung, Y. Zhu, S. Chu, J. Siau, B. Wong, et al. 2005. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem. Biophys. Res. Commun. 343: 303–310.
45. Wulff, H. 2008. New light on the “old” chloride channel blocker DIDS. ACS Chem. Biol. 3: 399–401.
46. Yan, S. K., T. Chang, H. Wang, L. Wu, R. Wang, and Q. H. Meng. 2006. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 351: 485–491.
47. Yusuf, M., B. Huat, A. Hsu, M. Whiteman, M. Bhatia, and P. Moore. 2005. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem. Biophys. Res. Commun. 333: 1146–1152.
48. Zheng, Y. F., D. Z. Dai, and Y. Dai. 2010. NaHS ameliorates diabetic vascular injury by correcting depressed connexin 43 and 40 in the vasculature in streptozotocin-injected rats. J. Pharm. Pharmacol. 62: 615–621.